SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Airaksinen MS, Titievsky A, Saarma M. 1999. GDNF family neurotrophic factor signaling: four masters, one servant? Mol Cell Neurosci 13: 313325.
  • Alves MM, Burzynski G, Delalande JM, Osinga J, van der Goot A, Dolga AM, de Graaff E, Brooks AS, Metzger M, Eisel UL, Shepherd I, Eggen BJ, Hofstra RM. 2010. KBP interacts with SCG10, linking Goldberg-Shprintzen syndrome to microtubule dynamics and neuronal differentiation. Hum Mol Genet 19: 36423651.
  • Amiel J, Espinosa-Parrilla Y, Steffann J, Gosset P, Pelet A, Prieur M, Boute O, Choiset A, Lacombe D, Philip N, Le Merrer M, Tanaka H, Till M, Touraine R, Toutain A, Vekemans M, Munnich A, Lyonnet S. 2001. Large-scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures. Am J Hum Genet 69: 13701377.
  • Amiel J, Laudier, B, Attie-Bitach T, Trang H, de Pontual L, Gener B, Trochet D, Etchevers H, Ray P, Simonneua M, Vekemans M, Munnich A, Gaultier C, Lyonnet S. 2003. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 33: 459460.
  • Amiel J, Rio M, de Pontual L, Redon R, Malan V, Boddaert N, Plouin P, Carter NP, Lyonnet S, Munnich A, Cooleaux L. 2007. Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet 80: 988993.
  • Angrist M, Bolk S, Halushka M, Lapchak PA, Chakravarti A. 1996. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Nat Genet 14: 341344.
  • Angrist M, Bolk S, Thiel B, Puffenberger EG, Hofstra RM, Buys CH, Cass DT, Chakravarti A. 1995. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum Mol Genet 4: 821830.
  • Arighi E, Popsueva A, Degl'Innocenti D, Borrello MG, Carniti C, Perälä NM, Pierotti MA, Sariola H. 2004. Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease. Mol Endocrinol 18: 10041017.
  • Attié T, Pelet A, Edery P, Eng C, Mulligan LM, Amiel J, Boutrand L, Beldjord C, Nihoul-Fékété C, Munnich A, Ponder Bruce AJ, Lyonnet S. 1995. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet 4: 13811386.
  • Auricchio A, Casari G, Staiano A, Ballabio A. 1996. Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population. Hum Mol Genet 5: 351354.
  • Badner JA, Sieber WK, Garver KL, Chakravarti A. 1990. A genetic study of Hirschsprung's disease. Am J Hum Genet 46: 568580.
  • Baloh, RH, Enomoto, H, Johnson, EM Jr, Milbrandt, J. 2000. The GDNF family ligands and receptors –implications for neural development. Curr Opin Neurobiol 10: 103110.
  • Barlow A, de Graaff E, Pachnis V. 2003. Enteric nervous system progenitors are coordinately controlled by the G protein coupled receptor EDNRB and the receptor tyrosine kinase RET. Neuron 40: 905916.
  • Baynash AG, Hosoda K, Giaid A, Richardson JA, Emoto N, Hammer RE, Yanagisawa M. 1994. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79: 12771285.
  • Bidaud C, Salomon R, Van Camp G, Pelet A, Attié T, Eng C, Bonduelle M, Amiel J, Nihoul-Fékété C, Willems PJ, Munnich A, Lyonnet S. 1997. Endothelin-3 gene mutations in isolated and syndromic Hirschsprung disease. Eur J Hum Genet 5: 247251.
  • Bolk S, Pelet A, Hofstra RM, Angrist M, Salomon R, Croaker D, Buys CH, Lyonnet S, Chakravarti A. 2000. A human model for multigenic inheritance: phenotypic expression in Hirschsprung's disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci USA 97: 268273.
  • Bordeaux MC, Forcet C, Granger L, Corset V, Bidaud C, Billaud M, Bredesen DE, Edery P, Mehlen P. 2000. The RET proto-oncogene induces apoptosis: a novel mechanism for Hirschsprung disease. EMBO J 19: 40564063.
  • Borrego S, Wright FA, Fernandez RM, Williams N, López-Alonso M, Davuluri R, Antiñolo G, Eng C. 2003. A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma. Am J Hum Genet 72: 88100.
  • Brooks AS, Bertoli-Avella AM, Burzynski GM, Breedveld GJ, Osinga J, Boven LG, Hurst JA, Mancini GM, Lequin MH, de Coo RF, Matera I, de Graaff E, Meijers C, Willems PJ, Tibboel D, Oostra BA, Hofstra RM. 2005. Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems. Am J Hum 77: 120126.
  • Brooks AS, Leegwater PA, Burzynski GM, Willems PJ, de Graaf B, van Langen I, Heutink P, Oostra BA, Hofstra RM, Bertoli-Avella AM. 2006. A novel susceptibility locus for Hirschsprung's disease maps to 4q31.3–q32.3. J Med Genet 43: 3540.
  • Burzynski GM, Nolte IM, Osinga J, Ceccherini I, Twigt B, Maas S, Brooks A, Verheij J, Plaza Menacho I, Buys CH, Hofstra RM. 2004. Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2. Euro J Hum Genet 12: 604612.
  • Carrasquillo MM, McCallion AS, Puffenberger EG, Kashuk CS, Nouri N, Chakravarti A. 2002. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat Genet 32: 237344.
  • Carter CO. 1969. Genetics of common disorders. Br Med Bull 25: 5257.
  • Carter MT, Yome JL, Marcil MN, Martin CA, Vanhorne JB, Mulligan LM. 2001. Conservation of RET proto-oncogene splicing variants and implications for RET isoform function. Cytogenet Cell Genet 95: 169176.
  • Chakravarti, A. 1996. Endothelin receptor-mediated signaling in Hirschsprung disease. Hum Molec Genet 5: 303307.
  • Chappuis- Flament S, Pasini A, De Vita G, Ségouffin-Cariou C, Fusco A, Attié T, Lenoir GM, Santoro M, Billaud M. 1998. Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines. Oncogene 17: 28512861.
  • Dastot-Le Moal F, Wilson M, Mowat D, Collot N, Niel F, Goossens M. 2007. ZFHX1B mutations in patients with Mowat-Wilson syndrome. Hum Mutat 28: 313321.
  • de Pontual L, Mathieu Y, Golzio C, Rio M, Malan V, Boddaert N, Soufflet C, Picard C, Durandy A, Dobbie A, Heron D, Isidor B, Motte J, Newburry-Ecob R, Pasquier L, Tardieu M, Viot G, Jaubert F, Munnich A, Colleaux L, Vekemans M, Etchevers H, Lyonnet S, Amiel J. 2009. Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome. Hum Mutat 30: 669676.
  • Donghi R, Sozzi G, Pierotti MA, Biunno I, Miozzo M, Fusco A, Grieco M, Santoro M, Vecchio G, Spurr NK. 1989. The oncogene associated with human papillary thyroid carcinoma (PTC) is assigned to chromosome 10 q11-q12 in the same region as multiple endocrine neoplasia type 2A (MEN2A). Oncogene 4: 521523.
  • Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA Jr. 1993. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2: 851856.
  • Doray B, Salomon R, Amiel J, Pelet A, Touraine R, Billaud M, Attié T, Bachy B, Munnich A, Lyonnet S. 1998. Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease. Hum Mol Genet 7: 14491452.
  • Durbec PL, Larsson-Blomberg LB, Schuchardt A, Costantini F, Pachnis V. 1996. Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts. Development 122: 349358.
  • Edery P, Lyonnet S, Mulligan LM, Pelet A, Dow E, Abel L, Holder S, Nihoul-Fékété C, Ponder BA, Munnich A. 1994. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367: 378380.
  • Edery P, Attié T, Amiel J, Pelet A, Eng C, Hofstra RM, Martelli H, Bidaud C, Munnich A, Lyonnet S. 1996. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet 12: 442444.
  • Eketjäll S, Ibáñez CF. 2002. Functional characterization of mutations in the GDNF gene of patients with Hirschsprung disease. Hum Mol Genet 11: 325329.
  • Elworthy S, Pinto JP, Pettifer A, Cancela ML, Kelsh RN. 2005. Phox2b function in the enteric nervous system is conserved in zebrafish and is sox10-dependent. Mech Dev 122: 659669.
  • Emison ES, McCallion AS, Kashuk CS, Bush RT, Grice E, Lin S, Portnoy ME, Cutler DJ, Green ED, Chakravarti A. 2005. A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature 14: 857863.
  • Emison ES, Garcia-Barcelo M, Grice EA, Lantieri F, Amiel J, Burzynski G, Fernandez RM, Hao L, Kashuk C, West K, Miao X, Tam PK, Griseri P, Ceccherini I, Pelet A, Jannot AS, de Pontual L, Henrion-Caude A, Lyonnet S, Verheij JB, Hofstra RM, Antiñolo G, Borrego S, McCallion AS, Chakravarti A. 2010. Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability. Am J Hum Genet 87: 6074.
  • Enomoto H, Araki T, Jackman A, Heuckeroth RO, Snider WD, Johnson EM Jr, Milbrandt J. 1998. GFRα1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron 21: 317324.
  • Fitze G, Appelt H, Konig IR, Görgens H, Stein U, Walther W, Gossen M, Schreiber M, Ziegler A, Roesner D, Schackert HK. 2003. Functional haplotypes of the RET proto-oncogene promoter are associated with Hirschsprung disease (HSCR). Hum Mol Genet 12: 32073214.
  • Fitze G, König IR, Paditz E, Serra A, Schläfke M, Roesner D, Ziegler A, Schackert HK. 2008. Compound effect of PHOX2B and RET gene variants in congenital central hypoventilation syndrome combined with Hirschsprung disease. Am J Med Genet A 146: 14861489.
  • Fusco A, Grieco M, Santoro M, Berlingieri MT, Pilotti S, Pierotti MA, Della Porta G, Vecchio G. 1987. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature 328: 170172.
  • Gabriel SB, Salomon R, Pelet A, Angrist M, Amiel J, Fornage M, Attié-Bitach T, Olson JM, Hofstra R, Buys C, Steffann J, Munnich A, Lyonnet S, Chakravarti A. 2002. Segregation at three loci explains familial and population risk in Hirschsprung's disease. Nat Genet 31: 8993.
  • Garcia-Barcelo M, Sham MH, Lui VC, Chen BL, Ott J, Tam PK. 2003. Association study of PHOX2B as a candidate gene for Hirschsprung's disease. Gut 52: 563567.
  • Garcia-Barcelo M, Ganster RW, Lui VC, Leon TY, So MT, Lau AM, Fu M, Sham MH, Knight J, Zannini MS, Sham PC, Tam PK. 2005. TTF-1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung's disease. Hum Mol Genet 15: 191204.
  • Garcia-Barceló MM, Fong PY, Tang CS. 2008a. Mapping of a Hirschsprung's disease locus in 3p21. Eur J Hum Genet 16: 833840.
  • Garcia-Barceló MM, Lau DK, Ngan ES, Leon TY, Liu T, So M, Miao X, Lui VC, Wong KK, Ganster RW, Cass DT, Croaker GD, Tam PK. 2008b. Evaluation of the NK2 homeobox 1 gene (NKX2–1) as a Hirschsprung's disease locus. Ann Hum Genet 72: 170177.
  • Garcia-Barceló MM, Tang CS, Ngan ES, Lui VC, Chen Y, So MT, Leon TY, Miao XP, Shum CK, Liu FQ, Yeung MY, Yuan ZW, Guo WH, Liu L, Sun XB, Huang LM, Tou JF, Song YQ, Chan D, Cheung KM, Wong KK, Cherny SS, Sham PC, Tam PK. 2009. Genome-wide association study identifies NRG1 as a susceptibility locus for Hirschsprung's disease. PNAS 106: 26942699.
  • Garver KL, Law JC, Garver B. 1985. Hirschsprung's disease: a genetic study. Clin Genet 28: 503508.
  • Gershon MD. 2010. Developmental determinants of the independence and complexity of the enteric nervous system. Trends Neurosci 33: 44656.
  • Gianino S, Grider JR, Cresswell J, Enomoto H, Heuckeroth RO. 2003. GDNF availability determines enteric neuron number by controlling precursor proliferation. Development 130: 21872198.
  • Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Höppener JW, van Amstel HK, Romeo G, Lips Cornells JM, Buys CH. 1994. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367: 375376.
  • Hofstra RM, Osinga J, Tan-Sindhunata G, Wu Y, Kamsteeg EJ, Stulp RP, van Ravenswaaij-Arts C, Majoor-Krakauer D, Angrist M, Chakravarti A, Meijers C, Buys CH. 1996. A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat Genet 12: 445447.
  • Hofstra RM, Valdenaire O, Arch E, Osinga J, Kroes H, Löffler BM, Hamosh A, Meijers C, Buys CH. 1999. A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE- 1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction. Am J Hum Genet 64: 304308.
  • Hofstra RM, Wu Y, Stulp RP, Elfferich P, Osinga J, Maas SM, Siderius L, Brooks AS, vd Ende JJ, Heydendael VM, Severijnen RS, Bax KM, Meijers C, Buys CH. 2000. RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems. Hum Mutat 15: 418429.
  • Hosoda K, Hammer RE, Richardson JA, Baynash AG, Cheung JC, Giaid A, Yanagisawa M. 1994. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79: 12671276.
  • Ishiguro Y, Iwashita T, Murakami H, Asai N, Iida K, Goto H, Hayakawa T, Takahashi M. 1999. The role of amino acids surrounding tyrosine 1062 in ret in specific binding of the shc phosphotyrosine-binding domain. Endocrinology 140: 39923998.
  • Iwashita T, Murakami H, Asai N, Takahashi M. 1996. Mechanism of ret dysfunction by Hirschsprung mutations affecting its extracellular domain. Hum Mol Genet 5: 15771580.
  • Iwashita T, Kurokawa K, Qiao S, Murakami H, Asai N, Kawai K, Hashimoto M, Watanabe T, Ichihara M, Takahashi M. 2001. Functional analysis of RET with Hirschsprung mutations affecting its kinase domain. Gastroenterology 121: 2433.
  • Jackson SR, Guner YS, Woo R, Randolph LM, Ford H, Shin CE. 2009. L1CAM mutation in association with X-linked hydrocephalus and Hirschsprung's disease. Pediatr Surg Int 25: 823825.
  • Kapur RP, Yost C, Palmiter RD. 1992. A transgenic model for studying development of the enteric nervous system in normal and aganglionic mice. Development 116: 167175.
  • Kelsh RN. 2006. Sorting out Sox10 functions in neural crest development. Bioessays 28: 788798.
  • Lang D, Epstein JA. 2003. Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. Hum Mol Genet. 12: 937945.
  • Lantieri F, Griseri P, Puppo F, Campus R, Martucciello G, Ravazzolo R, Devoto M, Ceccherini I. 2006. Haplotypes of the human RET proto-oncogene associated with Hirschsprung disease in the Italian population derive from a single ancestral combination of alleles. Ann Hum Genet 70: 1226.
  • Lee HO, Levorse JM, Shin MK. 2003. The endothelin receptor-B is required for the migration of neural crest-derived melanocyte and enteric neuron precursors. Dev Biol 259: 162175.
  • Lee M, Goodall J, Verastegui C, Ballotti R, Goding CR. 2000. Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2. J Biol Chem 275: 3797837983.
  • Li JC, Mi KH, Zhou JL, Busch L, Kuhnel W. 2001. The development of colon innervation in trisomy 16 mice and Hirschsprung's disease. World J Gastroenterol 7: 1621.
  • Liu C, Jin L, Hui L, Lou J, Luo C, Zhou X, Li JC. 2008. RET polymorphisms and the risk of Hirschsprung's disease in a Chinese population. J Hum Genet 53: 825833.
  • Liu CP, Li XG, Lou JT, Xue Y, Luo CF, Zhou XW, Chen F, Li X, Li M, Li JC. 2009. Association analysis of the PHOX2B gene with Hirschsprung disease in the Han Chinese population of Southeastern China. J Pediatr Surg 44: 18051811.
  • Lyons DA, Naylor SG, Mercurio S, Dominguez C, Talbot WS. 2008. KBP is essential for axonal structure, outgrowth and maintenance in zebrafish, providing insight into the cellular basis of Goldberg-Shprintzen syndrome. Development 135: 599608.
  • Martucciello G, Bicocchi MP, Dodero P, Lerone M, Silengo Cirillo M, Puliti A, Gimelli G, Romeo G, Jasonni V. 1992. Total colonic aganglionosis associated with interstitial deletion of the long arm of chromosome 10. Pediatr Surg Int 7: 308310.
  • McCallion AS, Chakravarti A. 2001. EDNRB/EDN3 and Hirschsprung disease type II. Pigment Cell Res 14: 161169.
  • McCallion AS, Emison ES, Kashuk CS, Bush RT, Kenton M, Carrasquillo MM, Jones KW, Kennedy GC, Portnoy ME, Green ED, Chakravarti A. 2003. Genomic variation in multigenic traits: Hirschsprung disease. Cold Spring Harb Symp Quant Biol 68: 373381.
  • Mehlen P, Bredesen DE. 2004. The dependence receptor hypothesis. Apoptosis 9: 3749.
  • Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Teleius H, Tunnacliffe A, Ponder BA. 1993. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363: 458460.
  • Myers SM, Salomon R, Goessling A, Pelet A, Eng C, von Deimling A, Lyonnet S, Mulligan LM. 1999. Investigation of germline GFR alpha-1 mutations in Hirschsprung's disease. J Med Genet 36: 217220.
  • Nakakimura S, Sasaki F, Okada T, Arisue A, Cho K, Yoshino M, Kanemura Y, Yamasaki M, Todo S. 2008. Hirschsprung's disease, acrocallosal syndrome, and congenital hydrocephalus: report of 2 patients and literature review. J Pediatr Surg 43: 1317.
  • Natarajan D, Marcos-Gutierrez C, Pachnis V, de Graaff E. 2002. Requirement of signalling by receptor tyrosine kinase RET for the directed migration of enteric nervous system progenitor cells during mammalian embryogenesis. Development 129: 51515160.
  • Paratore C, Eichenberger C, Suter U, Sommer L. 2002. Sox10 haploinsufficiency affects maintenance of progenitor cells in a mouse model of Hirschsprung disease. Hum Mol Genet 11: 30753085.
  • Parisi MA, Kapur RP, Neilson I, Hofstra RM, Holloway LW, Michaelis RC, Leppig KA. 2002. Hydrocephalus and intestinal aganglionosis: is L1CAM a modifier gene in Hirschsprung disease? Am J Med Genet; 108: 5156.
  • Pasini B, Borrello MG, Greco A, Bongarzone I, Luo Y, Mondellini P, Alberti L, Miranda C, Arighi E, Bocciardi R, Seri M, Barone V, Radice MT, Romeo G, Pierotti MA. 1995. Loss of function effect of RET mutations causing Hirschsprung disease. Nat Genet 10: 3540.
  • Peters-van der Sanden MJ, Kirby ML, Gittenberger-de Groot A, Tibboel D, Mulder MP, Meijers C. 1993. Ablation of various regions within the avian vagal neural crest has differential effects on ganglion formation in the fore-, min- and hindgut. Dev Dyn 196: 183194.
  • Pichel JG, Shen L, Sheng HZ, Granholm AC, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H, Westphal H. 1996. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382: 7376.
  • Pingault V, Bondurand N, Kuhlbrodt K, Goerich DE, Préhu MO, Puliti A, Herbarth B, Hermans-Borgmeyer I, Legius E, Matthijs G, Amiel J, Lyonnet S, Ceccherini I, Romeo G, Smith JC, Read AP, Wegner M, Goossens M. 1998. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet 18: 171173.
  • Pingault V, Ente D, Dastot-Le Moal F, Goossens M, Marlin S, Bondurand N. 2010. Review and update of mutations causing Waardenburg syndrome. Hum Mutat 31: 391406.
  • Plaza-Menacho I, Burzynski GM, de Groot JW, Eggen BJ, Hofstra RM. 2006. Current concepts in RET-related genetics, signaling and therapeutics. Trends Genet 22: 627636.
  • Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWit D, Yanagisawa M, Chakravart A. 1994. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79: 12571266.
  • Robins H, Press WH. 2005. Human microRNAs target a functionally distinct population of genes with AT-rich 3-UTRs. Proc Natl Acad Sci USA 102: 1555715562.
  • Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M, Kääriäinen H. 1994. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367: 377378.
  • Ruiz-Ferrer M, Torroglosa A, Luzón-Toro B, Fernández RM, Antiñolo G, Mulligan LM, Borrego S. 2011. Novel mutations at RET ligand genes preventing receptor activation are associated to Hirschsprung's disease. J Mol Med 89: 471480.
  • Salomon R, Attié T, Pelet A, Bidaud C, Eng C, Amiel J, Sarnacki S, Goulet O, Ricour C, Nihoul-Fékété C, Munnich A, Lyonnet S. 1996. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease. Nat Genet 14: 345347.
  • Sánchez-Mejías A, Watanabe Y, Fernández RM, López-Alonso M, Antiñolo G, Bondurand N, Borrego S. 2010. Involvement of SOX10 in the pathogenesis of Hirschsprung disease: report of a truncating mutation in an isolated patient. J Mol Med 88: 507514.
  • Schuchardt A., D'Agati V., Larsson-Blomberg L., Costantini F, Pachnis V. 1994. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367: 380383.
  • Sribudiani Y, Metzger M, Osinga J, Rey A, Burns AJ, Thapar N, Hofstra RM. 2011. Variants in RET associated with Hirschsprung's disease affect binding of transcription factors and gene expression. Gastroenterology 140: 572582.
  • Stanchina L, Baral V, Robert F, Pingault V, Lemort N, Pachnis V, Goossens M, Bondurand N. 2006. Interactions between Sox10, Edn3 and Ednrb during enteric nervous system and melanocyte development. Dev Biol 295: 232249.
  • Takahashi M, Iwashita T, Santoro M, Lyonnet S, Lenoir GM, Billaud M. 1999. Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function? Hum Mutat 13: 3316.
  • Tam PK, Garcia-Barceló M. 2009. Genetic basis of Hirschsprung's disease. Pediatr Surg Int 25: 543558.
  • Tang CS, Sribudiani Y, Miao XP, de Vries AR, Burzynski G, So MT, Leon YY, Yip BH, Osinga J, Hui KJ, Verheij JB, Cherny SS, Tam PK, Sham PC, Hofstra RM, Garcia-Barceló MM. 2010. Fine mapping of the 9q13 Hirschsprung's disease locus. Hum Genet 127: 675683.
  • Tang CS, Ngan ES, Tang WK, So MT, Cheng G, Miao XP, Leon TY, Leung BM, Hui KJ, Lui VH, Chen Y, Chan IH, Chung PH, Liu XL, Wong KK, Sham PC, Cherny SS, Tam PK, Garcia-Barcelo MM. 2012. Mutations in the NRG1 gene are associated with Hirschsprung disease. Hum Genet 131: 6776.
  • Theocharatos S, Kenny SE. 2008. Hirschsprung's disease: current management and prospects for transplantation of enteric nervous system progenitor cells. Early Hum Dev 84: 801804.
  • Torfs CP. 1998. An epidemiological study of Hirschsprung disease in a multiracial California population. In: The Third International Meetings: Hirschsprung disease and related neurocristopathies. Evian, France, 1998.
  • Tsuji S. 2010. Genetics of neurodegenerative diseases: insights from high-throughput resequencing. Hum Mol Genet 19: 6570.
  • Uesaka T, Nagashimada M, Yonemura S, Enomoto H. 2008. Diminished Ret expression compromises neuronal survival in the colon and causes intestinal aganglionosis in mice. J Clin Invest 118: 18901898.
  • Van de Putte T, Francis A, Nelles L, van Grunsven LA, Huylebroeck D. 2007. Neural crest specific removal of Zfhx1b in mouse leads to a wide range of neurocristopathies reminiscent of Mowat-Wilson syndrome. Hum Mol Genet 16: 14231436.
  • Vanhorne JB, Gimm O, Myers SM, Kaushik A, von Deimling A, Eng C, Mulligan LM. 2001. Cloning and characterization of the human GFRA2 locus and investigation of the gene in Hirschsprung disease. Hum Genet 108: 409415.
  • von RC, Gallouzi IE. 2008. Decoding ARE-mediated decay: is microRNA part of the equation? J Cell Biol 181: 189194.
  • Wakamatsu N, Yamada Y, Yamada K, Ono T, Nomura N, Taniguchi H, Kitoh H, Mutoh N, Yamanaka T, Mushiake K, Kato K, Sonta S, Nagaya M. 2001. Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease. Nautre Genet 27: 369370.
  • Yanagisawa H, Hammer RE, Richardson, Williams SC, Clouthier DE, Yanagisawa M. 1998. Role of endothelin-1/endothelin-A receptor-mediated signaling pathway in the aortic arch patterning in mice. J Clin Invest 102: 2233.
  • Zhang XN, Zhou MN, Qiu YQ, Ding SP, Qi M, Li JC. 2007. Genetic analysis of RET, EDNRB, and EDN3 genes and three SNPs in MCS+9.7 in Chinese Patients with isolated Hirschsprung disease. Biochem Genet 45: 523527.
  • Zweier C, Peippo MM, Hoyer J, Sousa S, Bottani A, Clayton-Smith J, Reardon W, Saraiva J, Cabral A, Gohring I, Devriendt K, de Ravel T, Bijlsma EK, Hennekam RC, Orrico A, Cohen M, Dreweke A, Reis A, Nurnberg P, Rauch A. 2007. Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet 80: 9941001.
  • Zweier C, Sticht H, Bijlsma EK, Clayton-Smith J, Boonen SE, Fryer A, Greally MT, Hoffmann L, den Hollander NS, Jongmans M, Kant SG, King MD, Lynch SA, McKee S, Midro AT, Park SM, Ricotti V, Tarantino E, Wessels M, Peippo M, Rauch A. 2008. Further delineation of Pitt-Hopkins syndrome: phenotypic and genotypic description of 16 novel patients. J Med Genet 45: 738744.